ERNA vs TFC · P/E 0.0, rev $582.0K vs rev $24.54B
Eterna Therapeutics Inc (ERNA) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
TFC (TFC) common stock.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. TFC currently screens at market cap $0.
Not investment advice. Open the ERNA and TFC stock pages for the full models.
Not investment advice.